Longevity & Anti-Aging Medicine

Hormone Replacement Therapy (HRT)

HGH, Sermorelin, Testosterone and HCG Treatments

Personalized and Customized Medicine

´Report Predicts Multiple Sclerosis Drug Market Will Reach $15.8bn in 2015´ Says visiongain Report

LONDON, November 25, 2011 /PRNewswire/ http://www.visiongain.com/Report/723/Multiple-Sclerosis-Treatment-World-Drug-Market-2012-2022 A new report by visiongain predicts that revenues for Continue Reading

MSRCNY Receives Approval For Groundbreaking Stem Cell Trial in Multiple Sclerosis

Contact: Pamela Levin, RN, Multiple Sclerosis Research Center of New York, work: +1-646-557-3858, cell: +1-917-453-5537, PLevin@imsmp.org; or David Audley, International Cellular Medicine Society, Continue Reading

Regulators back MS drug

European regulators have recommended approval of Merck's multiple sclerosis drug Rebif for additional uses. Read more: Regulators back MS drug Continue Reading

New treatment for Multiple Sclerosis: Cambridge University translates research at the bench into a drug at the bedside

The culmination of three decades of research in Cambridge has resulted in the exciting prospect of a new transformational treatment for multiple sclerosis. Read more from the original source: New Continue Reading

Multiple Sclerosis Drug Shows Promise In Late-Stage Trial

MRI scan: This image shows the brain of a patient who is suffering from multiple sclerosis. MS is due to the destruction ... Read More of the myelin sheaths around the axon nerve fibres of the brain Continue Reading

Opexa Announces Publication in Multiple Sclerosis Journal of Tovaxin® Phase IIb Clinical Trial Results

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. Go here to see the original: Opexa Announces Publication in Multiple Sclerosis Journal of Tovaxin® Phase IIb Clinical Trial Results Continue Reading

Acute Multiple Sclerosis – H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations

A presentation at the American Society of Nephrology 44th Annual Meeting, showed study results of H.P. Read the original post: Acute Multiple Sclerosis - H.P. Acthar® Gel Reduces Shows Promise Continue Reading

Bike Ride to Benefit Multiple Sclerosis Research

Hundreds of cyclists began a bike ride across the valley Saturday to help create a world free of multiple sclerosis. Go here to see the original: Bike Ride to Benefit Multiple Sclerosis Research Continue Reading

Genzyme Appoints Leaders for Multiple Sclerosis and Rare Disease Businesses

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today the appointment of William “Bill” Sibold as Head of Multiple Sclerosis (MS) and Continue Reading

Multiple Sclerosis conference set for Nov. 12 in Beachwood

The National Multiple Sclerosis Society, Ohio Buckeye Chapter and the Mellen Center for Multiple Sclerosis are hosting the third annual "What's Hot in MS?" conference, 8:30 a.m. to 1 p.m. Excerpt Continue Reading

Persian spice saffron holds potential treatment for multiple sclerosis

Washington, Nov 5 (ANI): An active ingredient in the Persian spice saffron may be used to treat diseases involving neuroinflammation, such as multiple sclerosis, according to Medical researchers at Continue Reading

Natural intestinal flora involved in the emergence of multiple sclerosis, study finds

Multiple sclerosis is caused by a combination of genetic and environmental factors. See the original post: Natural intestinal flora involved in the emergence of multiple sclerosis, study finds Continue Reading

Multiple Sclerosis Pill Proven Effective

An experimental multiple sclerosis pill was successful in a second clinical trial, Biogen Idec Inc. said Wednesday. Follow this link: Multiple Sclerosis Pill Proven Effective Continue Reading

UM-Flint group seeks study participants

FLINT — Faculty from the University of Michigan-Flint Physical Therapy Department are seeking volunteers to help with multiple sclerosis research. Follow this link: UM-Flint group seeks study Continue Reading

Teens Who Work Graveyard Shift Might Face Higher Risk of Multiple Sclerosis

Teenagers who perform shift work could face a higher risk of multiple sclerosis (MS), according to new research from Sweden. See the article here: Teens Who Work Graveyard Shift Might Face Higher Continue Reading

[Symptoms of Multiple Sclerosis] – Video

www.HermanMack.com Just taking a few minutes to share some of the wonderful symptoms that come along with MS. multiple sclerosis early symptoms multiple sclerosis multiple sclerosis symptoms Continue Reading

Significant Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with COPAXONE®

Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with ... See original here: Significant Reduced Continue Reading

Experimental MS Drug Shows Promise

WEDNESDAY, Oct. 5 (HealthDay News) -- A new oral drug for relapsing forms of multiple sclerosis appears to reduce relapse rates and disability progression, according to the results of a so-called Continue Reading

Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT® MRI

MELVILLE, N.Y., Oct. 5, 2011 /PRNewswire/ -- In a newly published paper, medical researchers at FONAR Corporation (NASDAQ-FONR) report a diagnostic breakthrough in multiple sclerosis (MS), based on Continue Reading

Merck, Ono developing oral multiple sclerosis drug

Merck KGaA said its Merck Serono unit will develop and market a pill for multiple sclerosis with Japan's Ono Pharmaceutical Co. to compete with a similar product made by Novartis AG Continue Continue Reading







Get our latest updates

Subscribe Via A Feed Reader



Archives